Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Revenue (2019 - 2025)

Historic Revenue for Madrigal Pharmaceuticals (MDGL) over the last 8 years, with Q3 2025 value amounting to $287.3 million.

  • Madrigal Pharmaceuticals' Revenue rose 36203.14% to $287.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $740.6 million, marking a year-over-year increase of 86421.18%. This contributed to the annual value of $180.1 million for FY2024, which is N/A changed from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Revenue stood at $287.3 million for Q3 2025, which was up 36203.14% from $212.8 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Revenue peaked at $287.3 million during Q3 2025, and registered a low of $14.6 million during Q2 2024.